2013Endocrine AbstractsRequires access

Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma

Thomas M. A. Kerkhofs, Éric Baudin, Massimo Terzolo, Bruno Allolio, Rita Chadarévian, Sophie Leboulleux, Franco Mantero, Harm Reinout Haak, Martin Faßnacht

Open publisher page 4 citations

Abstract

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

About this research paper

What this paper is about

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Key concepts: Mitotane, Adrenocortical carcinoma, Carcinoma, Key (lock), Medicine, Oncology, Internal medicine, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma — Research Paper | ScholarLens